首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >Does Strong and Diffuse PAX-8 Positivity Occur in Primary Lung Carcinoma? An Immunohistochemical Study of 418 Cases and Review of the Literature
【24h】

Does Strong and Diffuse PAX-8 Positivity Occur in Primary Lung Carcinoma? An Immunohistochemical Study of 418 Cases and Review of the Literature

机译:在原发性肺癌中发生强且弥漫性pax-8积极性吗? 418例免疫组织化学研究及文献综述

获取原文
获取原文并翻译 | 示例
           

摘要

When a patient with a history of carcinoma of a nonpulmonary site is found to have a lung nodule, distinction between primary lung carcinoma and metastatic carcinoma from the patient's known primary tumor often relies on immunohistochemical findings, especially in situations where clinical and radiologic features are atypical. In recent years, it has been shown that PAX-8 staining occurs in carcinomas of renal, gynecologic, and thyroid origin (among others) but only rarely in primary carcinomas of the lung.1"33 Despite the preponderance of evidence suggesting that PAX-8 is a helpful marker for distinguishing primary lung carcinoma from carcinomas of selected nonpulmonary sites, its utility has been called into question by rare PAX-8-positive lung carcinomas in a few series,4'8'21 and an unusually large number of PAX-8-positive lung carcinomas in one recent study.24 The extent and intensity of PAX-8 staining in these rare cases has not been well documented.
机译:当发现患有非玻利亚植物癌的患者有肺结节时,患者已知的原发性肿瘤的原发性肺癌和转移性癌之间的区别往往依赖于免疫组织化学发现,特别是在临床和放射学特征是非典型的情况下的情况 。 近年来,已经表明,PAX-8染色在肾,妇科和甲状腺源(等中)的癌中,但只有很少在肺部的原发性癌中,尽管有常见的证据表明pax- 8是区分原发性肺癌的有用标记,用于从选定的非玻璃位点的癌,它的效用被罕见的PAX-8阳性肺癌在几次,4'8'21和异常大量的PAX中被调用罕见的PAX-8阳性肺癌问题 -8阳性肺癌在最近的一项研究中.24这些罕见案例中PAX-8染色的程度和强度并未充分记录。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号